Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alterity Therapeutics (ATHE) Other Working Capital Changes (2016 - 2020)

Alterity Therapeutics has reported Other Working Capital Changes over the past 4 years, most recently at -$110441.0 for Q4 2018.

  • For Q4 2018, Other Working Capital Changes fell 336.64% year-over-year to -$110441.0; the TTM value through Dec 2018 reached -$66683.3, up 53.38%, while the annual FY2025 figure was $700863.1, 322.41% up from the prior year.
  • Other Working Capital Changes for Q4 2018 was -$110441.0 at Alterity Therapeutics, down from $143.75 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $46670.6 in Q4 2017 and troughed at -$110441.0 in Q4 2018.
  • A 4-year average of -$40939.8 and a median of -$33251.1 in 2015 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 146.53% in 2017 and later plummeted 336.64% in 2018.
  • Year by year, Other Working Capital Changes stood at -$33251.1 in 2015, then crashed by 201.62% to -$100293.2 in 2016, then skyrocketed by 146.53% to $46670.6 in 2017, then crashed by 336.64% to -$110441.0 in 2018.
  • Business Quant data shows Other Working Capital Changes for ATHE at -$110441.0 in Q4 2018, $143.75 in Q2 2018, and $46670.6 in Q4 2017.